trans,trans-2(4-methoxyphenyl)-4-(1-3-benzodiazol-5-yl)-1-(dibutylaminocarbonylmethyl)pyrrolidine-3-carboxylic acid,
ZD4054,
zibotentan,
Zibotentan,
186497-07-4,
Zibotentan (ZD4054),
ZD4054,
ZD-4054,
UNII-8054MM4902,
Zd 4054,
2-(4-(1,3,4-oxadiazol-2-yl)phenyl)-N-(3-methoxy-5-methylpyrazin-2-yl)pyridine-3-sulfonamide,
N-(3-Methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-3-pyridinesulfonamide,
N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-[4-(1,3,4-OXADIAZOL-2-YL)PHENYL]PYRIDINE-3-SULFONAMIDE,
8054MM4902,
Zibotentan(ZD4054),
Zibotentan, ZD-4054,
Zibotentan [USAN:INN:JAN],
Zibotentan,ZD4054,
Zibotentan(ZD4054)/,
Zibotentan (ZD 4054),
N-(3-methoxy-5-methyl-pyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide,
MLS006011121,
SCHEMBL847090,
Zibotentan (JAN/USAN/INN),
GTPL3539,
CHEMBL1628688,
Zibotentan, >=98% (HPLC),
CHEBI:94573,
CTK4D9252,
HMS3654H10,
BCP02389,
KS-00001CP7,
Zibotentan pound ZD4054 pound(c),
ZINC1491485,
ABP000461,
MFCD09955343,
s1456,
AKOS015909372,
API0005352,
CS-0492,
SB17118,
NCGC00242479-01,
NCGC00242479-02,
NCGC00242479-03,
AN-16670,
BC226080,
HY-10088,
SC-71677,
SMR004702902,
AB0000419,
LS-194046,
A5489,
FT-0768122,
SW219504-1,
X7520,
Z-130,
D07741,
W-3828,
L001670,
BRD-K31553034-001-01-4,
I14-33339,
ZD4054, 186497-07-4,
3-Pyridinesulfonamide, N-(3-methoxy-5-methylpyrazinyl)-2-(4-(1,3,4-oxadiazol-2-yl)phenyl)-,
3-Pyridinesulfonamide,N-(3-methoxy-5-methyl-2-pyrazinyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]-,
N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide.,
ZD4054, Zibotentan,
Zibotentan (JAN/INN),
Zibotentan [USAN:INN],
D02HVW,
cc-635,
C19H16N6O4S,
CID9910224,
A11006,
C511404,
trans,trans-2(4-methoxyphenyl)-4-(1-3-benzodiazol-5-yl)-1-(dibutylaminocarbonylmethyl)pyrrolidine-3-carboxylic acid,
23713-49-7,